Reuters: FDA requests more safety data on asthma drugs

[NaDiNe]

FDA requests more safety data on asthma drugs
      

WASHINGTON (Reuters) - U.S. health officials said on Wednesday they had requested more information from GlaxoSmithKline Plc and other makers of asthma drugs to further evaluate the safety of the medicines.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login